Metformin improves skin flap survival through nitric oxide system

Journal of Surgical Research

Volumn 192, Issue 2, 2014, Pages 686-691

  Taleb, Shayandokht ^a,b   Moghaddas, Peiman ^a   Balaei, Maryam Rahimi ^a   Taleb, Shabnam ^a   Rahimpour, Sina ^a   Abbasi, Ata ^a   Ejtemaei Mehr, Shahram ^a   Dehpour, Ahmad Reza ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Metformin; Nitric oxide; Preconditioning; Skin flap

Indexed keywords

ARGININE; METFORMIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ANTIDIABETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG POTENTIATION; LOW DRUG DOSE; MALE; NONHUMAN; RAT; SKIN FLAP SURVIVAL; SURVIVAL RATE; SYNTHESIS; VASODILATATION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GRAFT SURVIVAL; ISCHEMIC PRECONDITIONING; METABOLISM; PATHOLOGY; PLASTIC SURGERY; PROCEDURES; REPERFUSION INJURY; SKIN; SPRAGUE DAWLEY RAT; SURGICAL FLAPS; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT SURVIVAL; HYPOGLYCEMIC AGENTS; ISCHEMIC PRECONDITIONING; MALE; METFORMIN; NITRIC OXIDE; RATS, SPRAGUE-DAWLEY; RECONSTRUCTIVE SURGICAL PROCEDURES; REPERFUSION INJURY; SKIN; SURGICAL FLAPS;

EID: 84912061616     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.07.012     Document Type: Article

References (29)

1. Atalay C, Kockaya EA, Cetin B, Kismet K, Akay MT. Efficacy of topical nitroglycerin and transcutaneous electrical nerve stimulation on survival of random-pattern skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg 2003;37:10.
2. Kiumehr S, Demehri S, Rabbani S, Amanpour S, Mohagheghi MA, Dehpour AR. Preconditioning of the rat random-pattern skin flap: modulation by opioids. Br J Plast Surg 2005;58:58.
3. Matsumura H, Yoshizawa N, Vedder NB, Watanabe K. Preconditioning of the distal portion of a rat random-pattern skin flap. Br J Plast Surg 2001;54:58.
4. Nezami BG, Rahimpour S, Gholipour T, et al. Pharmacologic preconditioning of random-pattern skin flap in rats using local cyclosporine and FK-506: interaction with nitric oxide system. Ann Plast Surg 2007;59:435.
5. Afraz S, Kamran A, Moazzami K, Nezami BG, Dehpour AR. Protective effect of pharmacologic preconditioning with pioglitazone on random-pattern skin flap in rat is mediated by nitric oxide system. J Surg Res 2012;176:696.
6. Hosnuter M, Babuccu O, Kargi E, Altinyazar C. Dual preconditioning: effects of pharmacological plus ischemic preconditioning on skin flap survival. Ann Plast Surg 2003;50:398.
7. Davis BJ, Xie Z, Viollet B, Zou MH. Activation of the AMPactivated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006;55:496.
8. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med 2002;137:25.
9. Verma S, Bhanot S, McNeill JH. Decreased vascular reactivity in metformin-treated fructose-hypertensive rats. Metabolism 1996;45:1053.
10. Bhalla RC, Toth KF, Tan E, Bhatty RA, Mathias E, Sharma RV. Vascular effects of metformin. Possible mechanisms for its antihypertensive action in the spontaneously hypertensive rat. Am J Hypertens 1996;9:570.
11. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854.
12. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167.
13. Tian R, Musi N, D'Agostino J, Hirshman MF, Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001;104:1664.
14. Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RA. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem 2002;277:32552.
15. Fisslthaler B, Fleming I, Keseru B, Walsh K, Busse R. Fluid shear stress and NO decrease the activity of the hydroxymethylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxO1. Circ Res 2007;100:e12.
16. Hou X, Song J, Li XN, et al. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 2010;396:199.
17. Kravchuk E, Grineva E, Bairamov A, Galagudza M, Vlasov T. The effect of metformin on the myocardial tolerance to ischemia-reperfusion injury in the rat model of diabetes mellitus type II. Exp Diabetes Res 2011;2011:907496.
18. Calvert JW, Gundewar S, Jha S, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS - mediated signaling. Diabetes 2008;57:696.
19. Solskov L, Lofgren B, Kristiansen SB, et al. Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration. Basic Clin Pharmacol Toxicol 2008;103:82.
20. Bhamra GS, Hausenloy DJ, Davidson SM, et al. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol 2008;103:274.
21. Shafighi M, Fathi AR, Brun C, et al. Topical application of 17beta-estradiol (E2) improves skin flap survival through activation of endothelial nitric oxide synthase in rats. Wound Repair Regen 2012;20:740.
22. Gilliver SC, Ashworth JJ, Ashcroft GS. The hormonal regulation of cutaneous wound healing. Clin Dermatol 2007;25:56.
23. Katakam PV, Ujhelyi MR, Hoenig M, Miller AW. Metformin improves vascular function in insulin-resistant rats. Hypertension 2000;35:108.
24. Peuler JD. Opposing adrenergic actions of intravenous metformin on arterial pressure in female spontaneously hypertensive rats. Cardiovasc Res 1999;43:237.
25. Vourtsis SA, Spyriounis PK, Agrogiannis GD, Ionac M, Papalois AE. VEGF application on rat skin flap survival. J Invest Surg 2012;25:14.
26. Nezami BG, Rahimpour S, Sadeghi M, Sianati S, Anaraki DK, et al. Chronic lithium impairs skin tolerance to ischemia in random-pattern skin flap of rats. J Surg Res 2011;171:374.
27. Paiva M, Riksen NP, Davidson SM, et al. Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J Cardiovasc Pharmacol 2009;53:373.
28. Gribbe O, Samuelson UE, Wiklund NP. Effects of nitric oxide synthase inhibition on blood flow and survival in experimental skin flaps. J Plast Reconstr Aesthet Surg 2007;60:287.
29. Cordeiro PG, Mastorakos DP, Hu QY, Kirschner RE. The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps. Plast Reconstr Surg 1997;100:1227.